U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:U.S. Preventive Medicine Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013352
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
U.S. Preventive Medicine Inc (USPM) is a healthcare service center that provides wellness and care management services. The center offers preventive plan, a web-based or online health management platform for the clinical science of preventive medicine. Its preventive plan library provides information on topics, which include symptoms, health conditions and diseases, health and wellness, medical tests, surgical and other treatment procedures, prescription and over the counter medicines, nutritional supplements, complementary and alternative medicines, and self-help and support groups. USPM also provides solutions in the areas of cholesterol management, community action, depression management, diabetes preventive, eating your way to better health and exercise and activity, among others. It serves employers, health plans and providers, and consumers. USPM is headquartered in Jacksonville, Florida, the US.

U.S. Preventive Medicine Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
U.S. Preventive Medicine Raises US$2 Million In Venture Financing Round 9
U.S. Preventive Medicine Raises US$0.01 Million In Venture Financing 10
U.S. Preventive Medicine Raises US$0.05 Million In Venture Financing 11
U.S. Preventive Medicine Inc – Key Competitors 12
U.S. Preventive Medicine Inc – Key Employees 13
U.S. Preventive Medicine Inc – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Key Facts 2
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
U.S. Preventive Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
U.S. Preventive Medicine Raises US$2 Million In Venture Financing Round 9
U.S. Preventive Medicine Raises US$0.01 Million In Venture Financing 10
U.S. Preventive Medicine Raises US$0.05 Million In Venture Financing 11
U.S. Preventive Medicine Inc, Key Competitors 12
U.S. Preventive Medicine Inc, Key Employees 13

★海外企業調査レポート[U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Canadian Utilities Limited:企業の戦略・SWOT・財務分析
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NeuroLogica Corp-医療機器分野:企業M&A・提携分析
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WEC Energy Group Inc:企業の発電所・SWOT分析2018
    WEC Energy Group Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • CP All Public Company Limited (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Limited (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務分析
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CytoSorbents Corp (CTSO)-医療機器分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • Heron Resources Ltd:企業の戦略・SWOT・財務情報
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kawasaki Kisen Kaisha Ltd (9107):石油・ガス:M&Aディール及び事業提携情報
    Summary Kawasaki Kisen Kaisha Ltd (K Line) is a global logistics company. It provides land transportation, air transportation, marine transportation, and harbor transportation. It owns and operates dry bulk carriers, LNG carriers, tankers, car carriers and containerships. The company also provides s …
  • Gulf Oil Limited Partnership:企業の戦略・SWOT・財務情報
    Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ASKA Pharmaceutical Co Ltd (4514):製薬・医療:M&Aディール及び事業提携情報
    Summary ASKA Pharmaceutical Co Ltd (ASKA) is a pharmaceutical company that offers quasi-drugs, foods, medical devices and veterinary medicines. The company imports and export pharmaceuticals and medical devices. Its activities comprise production, drug information, and research and development servi …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Anheuser-Busch InBev NVSA (ABI):企業の財務・戦略的SWOT分析
    Anheuser-Busch InBev NVSA (ABI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Unibail-Rodamco-Westfield Se:企業の戦略・SWOT・財務分析
    Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report Summary Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ingersoll-Rand Plc (IR):電力:M&Aディール及び事業提携情報
    Summary Ingersoll-Rand Plc (Ingersoll-Rand) is an industrial manufacturer. It designs, manufactures, sells and services a portfolio of industrial and commercial products. The company’s offerings enhance the quality, energy efficiency and comfort of air in homes and buildings, transport and protect f …
  • Dohler GmbH:企業の戦略・SWOT・財務情報
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆